Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bos

Showing results (551-560 of 888) with videos related to

Pageof 89
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
A comparison of forward and inverse treatment planning for intensity-modulated radiotherapy of head and neck cancerWerner Bär, Marco Schwarz, Markus Alber, et al.
Blood|January 21, 2010
IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanismsElke De Bruyne, Tomas J Bos, Frans Schuit, et al.
American Journal of Ophthalmology|February 15, 1993
Birdshot chorioretinopathy and Lyme borreliosisM S Suttorp-Schulten, L Luyendijk, A P van Dam, et al.
ALTEX|October 16, 2023
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicantsYvonne C M Staal, Liesbeth Geraets, Barbara Rothen-Rutishauser, et al.
Medicine|January 14, 2022
Sex disparities in the effect of statins on lipid parameters: The PharmLines InitiativeNicholas B Hunt, Johanna E Emmens, Sylvi Irawati, et al.
Annals of Intensive Care|November 4, 2015
Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic controlRoosmarijn T M van Hooijdonk, Jan M Binnekade, Lieuwe D J Bos, et al.
Frontiers in Immunology|July 11, 2018
NKG2A Expression Is Not <i>per se</i> Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an <i>In Vitro</i> System Mimicking the Tumor MicroenvironmentNiken M Mahaweni, Femke A I Ehlers, Subhashis Sarkar, et al.
Bioconjugate Chemistry|January 17, 2002
Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeuticsRobbert J Kok, Astrid J Schraa, Erwin J Bos, et al.
Frontiers in Cardiovascular Medicine|June 17, 2022
Abnormal Right Ventricular Myocardial Performance Index Is Not Associated With Outcomes in Invasively Ventilated Intensive Care Unit Patients Without Acute Respiratory Distress Syndrome-<i>Post hoc</i> Analysis of Two RCTsCharalampos Pierrakos, Anna Geke Algera, Fabienne Simonis, et al.
Pharmacoepidemiology and Drug Safety|August 31, 2021
Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysisYuanyuan Wang, Job F M van Boven, Jens H J Bos, et al.
Pageof 89

Showing results (551-560 of 888) with videos related to

Sort By:
Pageof 89
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
A comparison of forward and inverse treatment planning for intensity-modulated radiotherapy of head and neck cancerWerner Bär, Marco Schwarz, Markus Alber, et al.
Blood|January 21, 2010
IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanismsElke De Bruyne, Tomas J Bos, Frans Schuit, et al.
American Journal of Ophthalmology|February 15, 1993
Birdshot chorioretinopathy and Lyme borreliosisM S Suttorp-Schulten, L Luyendijk, A P van Dam, et al.
ALTEX|October 16, 2023
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicantsYvonne C M Staal, Liesbeth Geraets, Barbara Rothen-Rutishauser, et al.
Medicine|January 14, 2022
Sex disparities in the effect of statins on lipid parameters: The PharmLines InitiativeNicholas B Hunt, Johanna E Emmens, Sylvi Irawati, et al.
Annals of Intensive Care|November 4, 2015
Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic controlRoosmarijn T M van Hooijdonk, Jan M Binnekade, Lieuwe D J Bos, et al.
Frontiers in Immunology|July 11, 2018
NKG2A Expression Is Not <i>per se</i> Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an <i>In Vitro</i> System Mimicking the Tumor MicroenvironmentNiken M Mahaweni, Femke A I Ehlers, Subhashis Sarkar, et al.
Bioconjugate Chemistry|January 17, 2002
Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeuticsRobbert J Kok, Astrid J Schraa, Erwin J Bos, et al.
Frontiers in Cardiovascular Medicine|June 17, 2022
Abnormal Right Ventricular Myocardial Performance Index Is Not Associated With Outcomes in Invasively Ventilated Intensive Care Unit Patients Without Acute Respiratory Distress Syndrome-<i>Post hoc</i> Analysis of Two RCTsCharalampos Pierrakos, Anna Geke Algera, Fabienne Simonis, et al.
Pharmacoepidemiology and Drug Safety|August 31, 2021
Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysisYuanyuan Wang, Job F M van Boven, Jens H J Bos, et al.
Pageof 89